The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]
Edwards Lifesciences Q2 results are better than expected
Edwards Lifesciences (NYSE:EW) stock has jumped in after-hours trading after the company reported Street-beating Q2 results and boosted it earnings outlook. The Irvine, Calif.–based artificial heart valves and hemodynamic monitoring company reported a loss of –$122 million, or –20¢ per share, off $925 million in revenue during the quarter ended June 30. For the same quarter […]
Eko lands $2.7m federal grant for heart disease detection study
Eko announced today that it received a $2.7 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH). Oakland, Calif.-based Eko said in a news release that the grant will be used to fund its collaborative work with Northwestern Medicine Bluhm Cardiovascular Institute as they validate algorithms to help screen for […]
Boston Scientific’s next-gen stroke prevention device gets FDA nod
The FDA has approved the next-generation of Boston Scientific’s (NYSE:BSX) Watchman left atrial appendage closure (LAAC) device, the company announced today. The Marlborough, Mass.-based company describes the Watchman FLX as a permanent implant designed to close off the left atrial appendage and thus reduce the risk of stroke without the bleeding danger associated with blood-thinners. It […]
Medical Alley startups achieve ‘relatively normal’ funding despite pandemic
Medical Alley Association member startups pulled in more than $256 million in funding through June, signaling a “relatively normal” first half of the year 2020 despite the COVID-19 pandemic and battered economy, according to the Minnesota-based trade group. In total, 40 companies raised $256,406,357 in the first 6 months of the year. The $1.75 million median […]
Cytosorbents announces $40m offering
CytoSorbents (OTC:CTSO) announced that it commenced an underwritten public offering of shares of its common stock worth $40 million. Monmouth Junction, N.J.-based CytoSorbents intends to grant underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in connection with the offering as well, according to a […]
Windtree names Hamill as new CFO
Drug- and medtech developer Windtree Therapeutics (NSDQ:WINT) today announced it named John Hamill as SVP and chief financial officer, replacing John Tattory, who is leaving to pursue other opportunities. Hamill joins the company, which develops drug product and devices to treat acute cardiovascular and pulmonary disease, with 30 years in the pharma, biopharma and clinical […]
MedTech 100 roundup: Industry hits pandemic peak
After five months since medtech stocks peaked before the COVID-19 pandemic rocked the markets, the industry inched back toward that pre-pandemic high. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 88.9 points at the end of last week (July 17). That total represents just a -3.7% […]
DTW podcast: Connect your devices before it’s too late
Twenty years ago when he was working at the Mayo Clinic, cardiologist Dr. David Hayes shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data. Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he […]
COVID-19 diagnostics sales boost Abbott’s Q2 results
Abbott (NYSE:ABT) beat the consensus forecast on Wall Street today — with sales of molecular diagnostics including COVID-19 tests more than tripling. The Abbott Park, Ill.-based healthcare giant reported profits of $537 million or 57¢ per share, on sales of $7.33 billion for the three months ended June 30, 2020, for a bottom-line plunge of –47% […]
FDA approves Edwards Lifesciences’ ready-to-implant aortic valved conduit
Edwards Lifesciences (NYSE:EW) announced today that FDA has approved its Konect Resilia aortic valved conduit (AVC). Edwards describes the Konect Resilia as the first ready-to-implant option for bio-Bentall procedures, a complex surgery that involves the replacement of a person’s aortic valve, aortic root and the ascending aorta. Surgeons find themselves having to perform nearly a third […]
